Shandong Boan Biotechnology Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 261.23 million compared to CNY 220.69 million a year ago. Net loss was CNY 119.51 million compared to CNY 153.3 million a year ago.

Basic loss per share from continuing operations was CNY 0.23 compared to CNY 0.31 a year ago.